Diagnos Laboratorium Utama Tbk. vs Garuda Indonesia (Persero) Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B), while Garuda Indonesia (Persero) Tbk. trades at Rp53 (market cap 21.58T). The key difference: Garuda Indonesia (Persero) Tbk. is far larger — about 70.1× Diagnos Laboratorium Utama Tbk.'s market cap. Which is the better fit depends on your goals.
| DGNS | GIAA | |
|---|---|---|
Market Cap | 308B | 21.58T |
Indicative Equilibrium Price | — | 53 |
Indicative Equilibrium Volume | — | 5.81K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →The Company is a state-owned airline of the republic of Indonesia and commercial air transportation service provider for passenger, cargo, and other services related to air transportation in Indonesia. The Company also provides services related aviation services, including repairs, maintenance and overhaul (MRO), aircraft, ground services, air tickets reservation and provision, and in fight catering, as well as travel services, tourism and hospitality.The Company was established on March 31, 1950 with the name of Garuda Indonesian Airways NV domiciled in Central Jakarta. In accordance with government regulations, in 1975 the company changed its form a Limited Liability Company (Persero) PT Garuda Indonesian Airways.
Read more on GIAA →